FDA Inspection 1261246 — Celerion Inc
The FDA completed an inspection of Celerion Inc on January 17, 2025 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 17, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lincoln, NE (United States)
Additional Details
Bioanalytical BA/BE